Study on the Impact of New Technology on the Surgery Cost for Uterine Cavity Lesions under DRG Payment
- VernacularTitle:DRG支付下新技术对子宫腔内病变手术的费用影响研究
- Author:
Xiaokun LIU
1
;
Weiguo ZHU
;
Xueqin SUN
;
Jimin ZHANG
;
Zhiwei LENG
;
Jiali TONG
Author Information
1. 中国医学科学院北京协和医院医疗保险管理处 北京 100730
- Publication Type:Journal Article
- Keywords:
medical new technology;
DRG;
medical development;
cost control;
strategy
- From:
Chinese Health Economics
2025;44(3):43-46
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the cost and structural impact of the new technology"transhysteroscopic mechanical rotary excision of abnormal uterine tissues"on the DRG group of"surgery for intrauterine lesions"under the DRG payment method,and to provide clinical data for supporting the development of the exclusion policy for the new technology and new items.Methods:Cases in which transhysteroscopic mechanical rotary excision of abnormal uterine tissues was used in the gynecology day unit of the Peking Union Medcial College Hospital from March 2022 to November 2023,which were paid for under the DRG group of"surgery for intrauterine pathology",were retrospectively analyzed for the impact of the new technology on the cost and structure of the cases.Results:The price of"transhysteroscopic mechanical rotary excision of abnormal uterine tissues"in the Beijing Medical Service Price Item Specification is 8 000 yuan(Class C out-of-pocket expenses),which is higher than the payment standard of 6 866 yuan for the NE19 group,and the use of this new technology significantly increased the total hospitalization medical cost,the out-of-pocket ratio of the patients and the surgical cost,which led to an increase in the burden of the patients and the loss of the hospitals.Conclusion:"Transhysteroscopic mechanical rotary excision of abnormal uterine tissue"has the advantages of improving patients'prognosis and accelerating recovery,shortening operation time,avoiding intraoperative thermal injuries,and shortening the learning curve of doctors,etc.Policy makers should take into account cost control,patients'prognosis and the development of medical technology,scientifically and prudently formulate the exclusion policy of the new technology,reasonably determine the payment standard,and make good use of the exclusion policy and the payment standard.
